← All diseases Rare and hereditary disorders

Hereditary ATTR amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (80)Meta-analysis (11)Treatment guideline (1)Phase 3 study (30)Randomized trial (23)Systematic review (15)Clinical trial (344)Review article (146)Early study (phase 1 or 2) (7)Case report (135)Laboratory or animal study (8)Commentary or editorial (72) Studies currently recruiting participants only (35)

Filter

Publications and studies (1285)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. (2022/08/09) ♡
• Nerve Conduction Studies of Dorsal Sural Nerve: Normative Data and Its Potential Application in ATTRv Pre-Symptomatic Subjects. (2022/08/04) ♡
• Amyloidogenicity assessment of transthyretin gene variants. (2022/08/01) ♡
• The Frequency of V122I Transthyretin Mutation in a Cohort of African American Individuals With Bilateral Carpal Tunnel Syndrome. (2022/07/26) ♡
• A pilot study of nailfold capillaroscopy in hereditary transthyretin amyloidosis. (2022/07/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives. (2022/07/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transthyretin amyloidosis with macro-creatine kinase. (2022/07/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Comparison of (99m)Tc-DPD Scintigraphy, CMR Imaging, and Echocardiography in Patients With V30M-Associated Hereditary Transthyretin Amyloidosis. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hereditary transthyretin amyloidosis: a case report. (2022/06/25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update. (2022/06/18) ♡
• Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis. (2022/06/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Late-Onset Hereditary Transthyretin Amyloidosis Val30Met in an Elderly Person in a Non-Endemic Area. (2022/06/16) ♡
• Reply to 'Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?'. (2022/06/16) ♡
• Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C? (2022/06/15) ♡
• A patient with hereditary transthyretin amyloidosis involving multiple cranial nerves due to a rare p.(Phe84Ser) variant. (2022/06/07) ♡
• [Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?]. (2022/06/03) ♡
• Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy. (2022/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Characterization of hereditary transthyretin cardiac amyloidosis in Spain. (2022/06/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation. (2022/06/01) ♡
• Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients. (2022/05/05) ♡
• High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP. (2022/05/01) ♡
• Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis. (2022/04/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The use of diflunisal for transthyretin cardiac amyloidosis: a review. (2022/03/01) ♡
• A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit. (2022/03/01) ♡
• The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis. (2022/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma. (2022/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A family with extremely early onset ATTRv amyloidosis and an F44S mutation in China. (2022/03/01) ♡
• Genetically confirmed transthyretin amyloidosis primarily diagnosed as hypertrophic cardiomyopathy. (2022/02/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgically treated intradural spinal manifestation of hereditary amyloidogenic transthyretin amyloidosis - A case report and scoping review of the literature. (2022/02/28) ♡
• Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries. (2022/02/04) ♡
• TTR Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis. (2022/02/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Esophageal Stricture: Not Your Usual Culprit? (2022/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intra-abdominal bleeding caused by amyloid transthyretin amyloidosis in the gastrointestinal tract: a case report. (2022/02/01) ♡
• Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy. (2022/02/01) ♡
• Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. (2022/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Yet another amyloidosis. (2022/02/01) ♡
• Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M. (2022/01/26) ♡
• Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis. (2022/01/01) ♡
• Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study. (2022/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to the letter "Comments on 'Pupillometry: An objective test to assess endocular hereditary transthyretin amyloidosis'", by Shinji Kakihara, Takao Hirano, Akira Imai, Teruyoshi Miyahara and Toshinori Murata. (2022/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Comments on pupillometry: An objective test to assess endocular hereditary transthyretin amyloidosis. (2022/01/01) ♡
• Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. (2022/01/01) ♡
• Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis. (2022/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Implications of screening for coexisting transthyretin amyloidosis and aortic stenosis. (2022/01/01) ♡
• Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy. (2022/01/01) ♡
• Synthesis and biological evaluation of quinolone derivatives as transthyretin amyloidogenesis inhibitors and fluorescence sensors. (2022/01/01) ♡
• Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy. (2022/01/01) ♡
• Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases. (2022/01/01) ♡
• A Study of Familial Amyloid Polyneuropathy Induced by the TTR Val30Leu Mutation in China. (2022/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.